4.7 Article

Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB

Journal

JOURNAL OF ETHNOPHARMACOLOGY
Volume 174, Issue -, Pages 37-44

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2015.07.039

Keywords

Bupleurum falcatum; Saikosaponin; Neuroinflammation; Anti-inflammatory effects; Microglia; Astrocytes

Funding

  1. National Research Foundation of Korea (NRF) - Korean Government MSIP [2008-0061888]
  2. Korean Health Technology R&D Project, Ministry of Health Welfare [B12002912010000100]
  3. National Research Foundation of Korea [2008-0061888] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Ethnopharmacological relevance: The root of Bupleurum falcatum L. (BF) has been used in traditional Korean and Chinese medicines for over 2000 years to treat infections, fever, and chronic liver diseases. Among the many active compounds in BF ethanol extract (BFE), saikosaponins exert pharmacological activities including anti-inflammatory effects. Activated microglial cells release a variety of pro-inflammatory substances, leading to neuronal cell death and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The aim of the present study was to investigate the mechanism of the anti-neuroinflammatory effects of BFE using lipopolysaccharide (LPS)-stimulated microglial cells and LPS-intraperitoneal injected C57BL/6 mice. Materials and methods: Dried roots of BF were extracted with 70% ethanol (tenfold volume) on a stirring plate for 24 h at room temperature to prepare BFE. Pure saikosaponins (SB3, SB4, and SD) were prepared by solvent extraction and column chromatography fractionation. BV2 murine microglial cells were treated with BFE or saikosaponins for 4 h and stimulated with LPS. Generation of nitric oxide (NO), inflammatory cytokines, and reactive oxygen species (ROS) from activated microglial cells were monitored. The effects of BFE on NF-kappa B activation were determined using RT-PCR, reporter assay, and immunostaining. The in vivo effects of BFE were also assessed by immunohistochemical staining of tissue sections from LPS-injected mouse brains. Results: Treatment with BFE or saikosaponins dose-dependently attenuated LPS-induced production of NO, iNOS mRNA, and ROS by 30-50%. They reduced LPS-mediated increases in the mRNA levels of IL-6, IL-1 beta, and TNF-alpha by approximately 30-70% without affecting cell viability, and decreased LPS-mediated NF-kappa B activity via reducing p65/RELA mRNA, transcriptional activity, and nuclear localization of NF-kappa B. BFE also reduced LPS-induced activation of microglia and astrocytes in the hippocampus and substantia nigra of LPS-injected mice. Conclusion: Our data suggest that BFE may be effective for reducing neuroinflammation-mediated neurodegeneration through suppressing NF-kappa B-mediated inflammatory pathways. (c) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available